Scios, Firm Agree on Plan for Alzheimer’s Drugs
Reuters
MOUNTAIN VIEW, Calif. — Scios Inc. said it agreed with Marion Merrell Dow Inc. to develop new therapies for Alzheimer’s disease.
Marion Merrell Dow will fund ongoing work at Scios in return for exclusive rights to develop and sell any drugs developed.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
